Status:
NOT_YET_RECRUITING
Survival Outcome After Minilaparotomy for the Treatment of Colorectal Cancer
Lead Sponsor:
Changhai Hospital
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The primary aim of this study is \- to determine the difference of survival outcome (3-year overall survival, 3y OS) between after minilaparotomy and after laparoscopy.. Other aims include to determ...
Eligibility Criteria
Inclusion
- Colorectal cancer with pathological results.
- Colorectal cancer preliminary diagnosed during colonoscopy.
- No confirmed metastasis.
- No comorbidity of other malignancy.
- The primary tumor is less than 10 cm.
- No organ dysfunction.
- The patient and his families totally agree with the whole investigative procedure, and sign the written informed consent form.
Exclusion
- Diagnosed with any other malignancy within 5 years.
- Comorbidity of emergent conditions like perforation.
- Former colorectal surgery history which may affects digestive tract reconstruction.
- Need combined organ resection.
- ASA grade IV or V.
- Pregnant or lactating Women.
- Severe mental diseases.
- Severe cardiopulmonary diseases which reduce operation tolerance.
- Systematic steroid therapy lasting for more than 1 month.
- Intolerant of laparoscopy.
- No written informed consent form signed.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
992 Patients enrolled
Trial Details
Trial ID
NCT03843398
Start Date
April 1 2019
End Date
April 1 2026
Last Update
February 18 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.